首页> 外文会议>First International Workshop on the Application of High Intensity Focused Ultrasound (Hifu) in Medicine, May 10-12, 2001, Chongqing, China >Extracorporeal Ablation of Breast Cancer with Focused Ultrasound Surgery@Experimental Study and 3-year Preliminary Clinical Results
【24h】

Extracorporeal Ablation of Breast Cancer with Focused Ultrasound Surgery@Experimental Study and 3-year Preliminary Clinical Results

机译:聚焦超声手术对乳腺癌的体外消融@实验研究和3年初步临床结果

获取原文
获取原文并翻译 | 示例

摘要

To our knowledge, the significant data presented in this paper reveal for the first time that human breast cancer can be completely ablated with extracorporeal FUS treatment and that the main histological change is coagulative necrosis, followed by the processes of tissue resorption and granulation tissue formation. The 3-year clinical experience suggested that FUS is a safe, effective and feasible modality for the treatment of human breast cancer. Although early results of this noninvasive technique are encouraging and exiting, longer follow-up and large-scale clinical trials are necessary to fully determine the true efficacy of this breast conservation modality.
机译:据我们所知,本文提供的重要数据首次揭示了体外FUS治疗可以完全消融人乳腺癌,其主要的组织学变化是凝集性坏死,其次是组织吸收和肉芽组织形成过程。三年的临床经验表明,FUS是治疗人类乳腺癌的安全,有效和可行的方法。尽管这种无创技术的早期结果令人鼓舞并已消失,但仍需要更长的随访和大规模临床试验才能充分确定这种保乳方式的真正功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号